This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Compared with sevoflurane, a combination of remimazolam and flumazenil reduced the time to extubation in patients undergoing transcatheter aortic valve implantation by approximately 7 minutes, a study found.
Medscape Medical News